{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:06:28Z","timestamp":1789596388968,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["94-01-08-11247"],"award-info":[{"award-number":["94-01-08-11247"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00520-019-04684-6","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T06:23:33Z","timestamp":1549520613000},"page":"1325-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Zahra","family":"Keshavarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-8401","authenticated-orcid":false,"given":"Roksana","family":"Janghorban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Jokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"4684_CR1","volume-title":"Berek and Novak\u2019s gynecology","author":"JS Berek","year":"2012","unstructured":"Berek JS (2012) Berek and Novak\u2019s gynecology. Lippincott Williams and Wilkins, Philadelphia"},{"issue":"3","key":"4684_CR2","first-page":"430","volume":"44","author":"M Enayatrad","year":"2015","unstructured":"Enayatrad M, Amoori N, Salehiniya H (2015) Epidemiology and trends in breast cancer mortality in Iran. Iran J Public Health 44(3):430\u2013431","journal-title":"Iran J Public Health"},{"issue":"3","key":"4684_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jama.2011.991","volume":"306","author":"L Mastro Del","year":"2011","unstructured":"Del Mastro L, Boni L, Michelotti A et al (2011) Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 306(3):269\u2013276. https:\/\/doi.org\/10.1001\/jama.2011.991","journal-title":"JAMA"},{"issue":"3","key":"4684_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5152\/ejbh.2017.3583","volume":"13","author":"M Costa","year":"2017","unstructured":"Costa M, Saldanha P (2017) Risk reduction strategies in breast cancer prevention. Eur J Breast Health 13(3):103\u2013112. https:\/\/doi.org\/10.5152\/ejbh.2017.3583","journal-title":"Eur J Breast Health"},{"key":"4684_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1472-6874-6-14","volume":"6","author":"NN Kim","year":"2006","unstructured":"Kim NN, Stankovic M, Armagan A, Cushman TT, Goldstein I, Traish AM (2006) Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. BMC Womens Health 6:14","journal-title":"BMC Womens Health"},{"issue":"1","key":"4684_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00192-017-3490-5","volume":"26","author":"MA Weber","year":"2015","unstructured":"Weber MA, Limpens J, Roovers JPWR (2015) Assessment of vaginal atrophy: a review. Int Urogynecol J 26(1):15\u201328. https:\/\/doi.org\/10.1007\/s00192-017-3490-5","journal-title":"Int Urogynecol J"},{"issue":"6","key":"4684_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","volume":"20","author":"DJ Portman","year":"2013","unstructured":"Portman DJ, Bachmann GA, Simon JA, Group OS (2013) Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 20(6):623\u2013630. https:\/\/doi.org\/10.1097\/gme.0b013e318279ba64","journal-title":"Menopause"},{"key":"4684_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejca.2017.07.012","volume":"84","author":"J Simin","year":"2017","unstructured":"Simin J, Tamimi R, Lagergren J, Adami HO, Brusselaers N (2017) Menopausal hormone therapy and cancer risk: an overestimated risk? Eur J Cancer 84:60\u201368. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.012","journal-title":"Eur J Cancer"},{"issue":"2","key":"4684_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ijc.27623","volume":"132","author":"B Trabert","year":"2013","unstructured":"Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA (2013) Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer 132(2):417\u2013426. https:\/\/doi.org\/10.1002\/ijc.27623","journal-title":"Int J Cancer"},{"key":"4684_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.steroids.2014.12.013","volume":"99","author":"SB Brown","year":"2015","unstructured":"Brown SB, Hankinson SE (2015) Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids 99:8\u201310. https:\/\/doi.org\/10.1016\/j.steroids.2014.12.013","journal-title":"Steroids"},{"issue":"6","key":"4684_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/GME.0000000000000611","volume":"23","author":"A Bergendal","year":"2016","unstructured":"Bergendal A, Kieler H, Sundstr\u00f6m A, Hirschberg AL, Kocoska-Maras L (2016) Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Menopause 23(6):593\u2013599. https:\/\/doi.org\/10.1097\/GME.0000000000000611","journal-title":"Menopause"},{"issue":"4","key":"4684_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1758834016687260","volume":"9","author":"MS Sousa","year":"2017","unstructured":"Sousa MS, Peate M, Jarvis S, Hickey M, Friedlander M (2017) A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Ther Adv Med Oncol 9(4):269\u2013285. https:\/\/doi.org\/10.1177\/1758834016687260","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"4684_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jpm5020050","volume":"5","author":"J Lester","year":"2015","unstructured":"Lester J, Pahouja G, Andersen B, Lustberg M (2015) Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med 5(2):50\u201366. https:\/\/doi.org\/10.3390\/jpm5020050","journal-title":"J Pers Med"},{"issue":"6","key":"4684_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/GME.0000000000001121","volume":"25","author":"SS Faubion","year":"2018","unstructured":"Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JAV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA (2018) Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women\u2019s Sexual Health. Menopause 25(6):596\u2013608. https:\/\/doi.org\/10.1097\/GME.0000000000001121","journal-title":"Menopause"},{"issue":"3","key":"4684_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/AOG.0000000000001349","volume":"127","author":"R Farrell","year":"2016","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Gynecologic Practice, Farrell R (2016) ACOG Committee Opinion No. 659 Summary: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol 127(3):618\u2013619. https:\/\/doi.org\/10.1097\/AOG.0000000000001349","journal-title":"Obstet Gynecol"},{"issue":"6","key":"4684_CR16","first-page":"411","volume":"12","author":"D Costantino","year":"2008","unstructured":"Costantino D, Guaraldi C (2008) Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial. Eur Rev Med Pharmacol Sci 12(6):411\u2013416","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"4684_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","volume":"117","author":"YK Lee","year":"2011","unstructured":"Lee YK, Chung HH, Kim JW, Park NH, Song YS, Kang SB (2011) Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol 117(4):922\u2013927. https:\/\/doi.org\/10.1097\/AOG.0b013e3182118790","journal-title":"Obstet Gynecol"},{"issue":"3","key":"4684_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.maturitas.2012.12.002","volume":"74","author":"GT Wurz","year":"2013","unstructured":"Wurz GT, Soe LH, DeGregorio MW (2013) Ospemifene, vulvovaginal atrophy, and breast cancer. Maturitas 74(3):220\u2013225. https:\/\/doi.org\/10.1016\/j.maturitas.2012.12.002","journal-title":"Maturitas"},{"issue":"2","key":"4684_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1743-6109.2010.01988.x","volume":"8","author":"J Carter","year":"2011","unstructured":"Carter J, Goldfrank D, Schover LR (2011) Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 8(2):549\u2013559. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.01988.x","journal-title":"J Sex Med"},{"issue":"Suppl 1","key":"4684_CR20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3747\/co.2007.151","volume":"14","author":"C Derzko","year":"2007","unstructured":"Derzko C, Elliott S, Lam W (2007) Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 14(Suppl 1):S20\u2013S40","journal-title":"Curr Oncol"},{"issue":"10","key":"4684_CR21","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/jsm.12156","volume":"10","author":"I Juraskova","year":"2013","unstructured":"Juraskova I, Jarvis S, Mok K, Peate M, Meiser B, Cheah BC, Mireskandari S, Friedlander M (2013) The acceptability, feasibility, and efficacy (phase I\/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med 10(10):2549\u20132558. https:\/\/doi.org\/10.1111\/jsm.12156","journal-title":"J Sex Med"},{"issue":"1","key":"4684_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-015-3434-z","volume":"152","author":"S Mazzarello","year":"2015","unstructured":"Mazzarello S, Hutton B, Ibrahim MF et al (2015) Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat 152(1):1\u20138. https:\/\/doi.org\/10.1007\/s10549-015-3434-z","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4684_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.maturitas.2004.02.008","volume":"49","author":"B Yildirim","year":"2004","unstructured":"Yildirim B, Kaleli B, D\u00fczcan E, Topuz O (2004) The effects of postmenopausal vitamin D treatment on vaginal atrophy. Maturitas 49(4):334\u2013337","journal-title":"Maturitas"},{"key":"4684_CR24","unstructured":"Rad P, Tadayon M, Abbaspour M, Latifi SM, Rashidi I, Delaviz H The effect of vitamin D on vaginal atrophy in postmenopausal women. Iran J Nurs Midwifery Res 20(2):211\u2013215"},{"issue":"9","key":"4684_CR25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.14348\/molcells.2017.0026","volume":"40","author":"A Lee","year":"2017","unstructured":"Lee A, Lee MR, Lee HH et al (2017) Vitamin D proliferates vaginal epithelium through RhoA expression in postmenopausal atrophic vagina tissue. Mol Cell 40(9):677\u2013684","journal-title":"Mol Cell"},{"issue":"4","key":"4684_CR26","first-page":"12","volume":"2","author":"S Ziagham","year":"2013","unstructured":"Ziagham S, Abbaspoor Z, Safyari S, Rad P (2013) Effect of vitamin E vaginal suppository on atrophic vaginitis among postmenopausal women. Jundishapur J Chronic Dis Care 2(4):12\u201319","journal-title":"Jundishapur J Chronic Dis Care"},{"key":"4684_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4081\/1200","volume":"52","author":"G Abban","year":"2008","unstructured":"Abban G, Yildirim NB, Jetten AM (2008) Regulation of the vitamin D receptor and cornifin beta expression in vaginal epithelium of the rats through vitamin D3. Eur J Histochem 52:107\u2013104","journal-title":"Eur J Histochem"},{"issue":"2","key":"4684_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.fertnstert.2006.11.112","volume":"88","author":"HB Zeyneloglu","year":"2007","unstructured":"Zeyneloglu HB, Oktem M, Haberal NA, Esinler I, Kuscu E (2007) The effect of raloxifene in association with vitamin D on vaginal maturation index and urogenital symptoms in postmenopausal osteoporotic women. Fertil Steril 88(2):530\u2013532","journal-title":"Fertil Steril"},{"issue":"5","key":"4684_CR29","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/gme.0b013e3181a06c80","volume":"16","author":"JA Chollet","year":"2009","unstructured":"Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL (2009) Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause 16(5):978\u2013983. https:\/\/doi.org\/10.1097\/gme.0b013e3181a06c80","journal-title":"Menopause"},{"issue":"4","key":"4684_CR30","first-page":"823","volume":"102","author":"L Speroff","year":"2003","unstructured":"Speroff L (2003) Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. Obstet Gynecol 102(4):823\u2013834","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4684_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0193945910391483","volume":"34","author":"J Lester","year":"2012","unstructured":"Lester J, Bernhard L, Ryan-Wenger N (2012) A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res 34(1):72\u201396. https:\/\/doi.org\/10.1177\/0193945910391483","journal-title":"West J Nurs Res"},{"issue":"6","key":"4684_CR32","first-page":"57","volume":"15","author":"Z Ziagham","year":"2012","unstructured":"Ziagham Z, Abbaspoor Z, Abbaspour MR (2012) The comparison between the effects of hyaluronic acid vaginal suppository and vitamin e on the treatment of atrophic vaginitis in menopausal women. J Arak Uni Med Sci 15(6):57\u201364","journal-title":"J Arak Uni Med Sci"},{"issue":"4","key":"4684_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.22038\/JMRH.2014.3246","volume":"2","author":"AZ Emamverdikhan","year":"2014","unstructured":"Emamverdikhan AZ, Golmakani N, SharifiSistani N, Shakeri MT, Hasanzade Mofrad M, Sajadi Tabassi A (2014) Comparing two treatment methods of vitamin E suppository and conjugated estrogen vaginal cream on the quality of life in menopausal women with vaginal atrophy. J Midwif Reprod Health 2(4):253\u2013261. https:\/\/doi.org\/10.22038\/JMRH.2014.3246","journal-title":"J Midwif Reprod Health"},{"issue":"3","key":"4684_CR34","first-page":"230","volume":"56","author":"G Morali","year":"2006","unstructured":"Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marr\u00e8 GB (2006) Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung 56(3):230\u2013238","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"4684_CR35","first-page":"523","volume":"67","author":"S Dinicola","year":"2015","unstructured":"Dinicola S, Pasta V, Costantino D, Guaraldi C, Bizzarri M (2015) Hyaluronic acid and vitamins are effective in reducing vaginal atrophy in women receiving radiotherapy. Minerva Ginecol 67(6):523\u2013531","journal-title":"Minerva Ginecol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-04684-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:10:26Z","timestamp":1720973426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-04684-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4684"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-04684-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research project was approved by the ethics committee of Shiraz University of Medical Sciences (IR.SUMS.REC 94-01-08-11247) and registered at the Iranian Registry of Clinical Trials (IRCT2016100229683N2).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}